Overview of Probenecid And Colchicine
| Property | Description |
|---|---|
| Active ingredient | Probenecid and Colchicine |
| Form | Fixed-dose combination oral tablet |
| Pharmacological class | Uricosuric combination, Anti-gout agent |
| General purpose | Management of hyperuricemia and chronic gout |
| Origin | Synthetic (Probenecid) and Natural Alkaloid (Colchicine) |
Probenecid And Colchicine is a prescription-only medication formulated as a fixed-dose combination oral tablet utilized for the long-term management of high blood uric acid levels, known as hyperuricemia, a condition central to gout. This medicine is recognized as a uricosuric combination, a type of anti-gout agent that provides a synergistic, two-pronged approach to the chronic condition.
Composition and Origin of the Dual-Action Tablet
The oral tablet contains two primary active ingredients, Probenecid and Colchicine, which function together to achieve a beneficial pharmacological synergy. Probenecid is a compound classified as synthetic that primarily aids in the removal of uric acid, while Colchicine is an alkaloid derived from a natural source that exhibits an anti-inflammatory agent effect. The fixed ratio of the two agents in this combination therapy is a key feature, intended to ensure the patient receives continuous, multi-targeted support for both metabolic correction and inflammatory management.
Probenecid's main role is enhancing the uric acid excretion in the kidneys, which ultimately lowers the concentration of urate in the blood.
General Purpose: Why Use a Uricosuric Combination?
The general purpose of this medication is to achieve and sustain reduced serum urate levels and contribute to the long-term stability necessary for patients managing chronic gouty arthritis. By combining an agent that promotes uric acid excretion with one that disrupts the activity of inflammatory cells, the medicine helps decrease the overall body burden of uric acid. This dual approach is regarded as an effective strategy for preventing the recurrence of painful gout episodes, addressing both the cause and effect of the condition.
Regulatory References

